现代中西医结合杂志
現代中西醫結閤雜誌
현대중서의결합잡지
MODERN JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
26期
2862-2863,2964
,共3页
张丽坤%周凤娇%苏彦君%张建勇%安志霞
張麗坤%週鳳嬌%囌彥君%張建勇%安誌霞
장려곤%주봉교%소언군%장건용%안지하
青蒿素%金属蛋白酶-2组织抑制物%基质金属蛋白酶-2%糖尿病肾病
青蒿素%金屬蛋白酶-2組織抑製物%基質金屬蛋白酶-2%糖尿病腎病
청호소%금속단백매-2조직억제물%기질금속단백매-2%당뇨병신병
artemisinin%diabetic nephropathy%tissue inhibitor of metalloproteinase -2%matrix metalloproteinase -2
目的:探讨青蒿素对糖尿病大鼠肾基质金属蛋白酶-2(MMP-2)及其抑制物金属蛋白酶-2组织抑制物( TIMP-2)表达的调节作用。方法将大鼠随机分为对照组( A组)、糖尿病非治疗组(B组)及糖尿病青蒿素治疗组(C组),采用腹腔单剂量注射链脲佐菌素(STZ)65 mg/kg方法以建立糖尿病大鼠模型。 C组给予青蒿素300 g/( kg· d)腹腔注射。实验进行到第3周、第6周时3组分别宰杀大鼠6只,检测肾质量/体质量、24 h尿白蛋白排泄率(UAER)及肌酐清除率(Ccr)。用免疫组化染色方法分别检测肾小球Ⅳ型胶原、TIMP-2、MMP-2和纤维连接蛋白( FN)表达情况。结果 C组大鼠Ccr、UAER、肾质量/体质量均显著低于B组(P<0.05或0.01)。免疫组化染色证明糖尿病大鼠肾小球Ⅳ型胶原、FN和TIMP-2表达都明显上调(P<0.05或0.01),C组上述指标的表达都被显著抑制(P<0.05)。 MMP-2在B组大鼠肾小球的表达显著下调(P<0.01),C组其表达显著上调(P<0.05)。结论青蒿素通过抑制糖尿病大鼠肾小球TIMP-2表达及增加 MMP-2表达,从而保护糖尿病实验大鼠肾脏功能。
目的:探討青蒿素對糖尿病大鼠腎基質金屬蛋白酶-2(MMP-2)及其抑製物金屬蛋白酶-2組織抑製物( TIMP-2)錶達的調節作用。方法將大鼠隨機分為對照組( A組)、糖尿病非治療組(B組)及糖尿病青蒿素治療組(C組),採用腹腔單劑量註射鏈脲佐菌素(STZ)65 mg/kg方法以建立糖尿病大鼠模型。 C組給予青蒿素300 g/( kg· d)腹腔註射。實驗進行到第3週、第6週時3組分彆宰殺大鼠6隻,檢測腎質量/體質量、24 h尿白蛋白排洩率(UAER)及肌酐清除率(Ccr)。用免疫組化染色方法分彆檢測腎小毬Ⅳ型膠原、TIMP-2、MMP-2和纖維連接蛋白( FN)錶達情況。結果 C組大鼠Ccr、UAER、腎質量/體質量均顯著低于B組(P<0.05或0.01)。免疫組化染色證明糖尿病大鼠腎小毬Ⅳ型膠原、FN和TIMP-2錶達都明顯上調(P<0.05或0.01),C組上述指標的錶達都被顯著抑製(P<0.05)。 MMP-2在B組大鼠腎小毬的錶達顯著下調(P<0.01),C組其錶達顯著上調(P<0.05)。結論青蒿素通過抑製糖尿病大鼠腎小毬TIMP-2錶達及增加 MMP-2錶達,從而保護糖尿病實驗大鼠腎髒功能。
목적:탐토청호소대당뇨병대서신기질금속단백매-2(MMP-2)급기억제물금속단백매-2조직억제물( TIMP-2)표체적조절작용。방법장대서수궤분위대조조( A조)、당뇨병비치료조(B조)급당뇨병청호소치료조(C조),채용복강단제량주사련뇨좌균소(STZ)65 mg/kg방법이건립당뇨병대서모형。 C조급여청호소300 g/( kg· d)복강주사。실험진행도제3주、제6주시3조분별재살대서6지,검측신질량/체질량、24 h뇨백단백배설솔(UAER)급기항청제솔(Ccr)。용면역조화염색방법분별검측신소구Ⅳ형효원、TIMP-2、MMP-2화섬유련접단백( FN)표체정황。결과 C조대서Ccr、UAER、신질량/체질량균현저저우B조(P<0.05혹0.01)。면역조화염색증명당뇨병대서신소구Ⅳ형효원、FN화TIMP-2표체도명현상조(P<0.05혹0.01),C조상술지표적표체도피현저억제(P<0.05)。 MMP-2재B조대서신소구적표체현저하조(P<0.01),C조기표체현저상조(P<0.05)。결론청호소통과억제당뇨병대서신소구TIMP-2표체급증가 MMP-2표체,종이보호당뇨병실험대서신장공능。
Objective It is to explore the regular effect of artemisinin on the expression of MMP -2 and TIMP-2 in dia-betic rats.Methods The rats were randomly divided into control group ( A group), diabetic group with nontreatment ( B group),diabetic group treated with artemisinin (C group).The diabetic rat models were established by intraperitoneal injec-tion with STZ 65mg/kg.Group C was given artemisinin 300 g/( kg· d) by intraperitoneal injection .6 rats in the three groups were killed to determine kidney weight/body weight, Ccr, UAER after 3 and 6 weeks of treatment with artemisinin , mean-while FN, TIMP-2, collagen Ⅳ protein and MMP-2 expressions were measured by immunohistological staining .Results Ccr, UAER and kidney/body weight ratio in the rats of group C were significantly lower than those of the rats in group B ( P<0.05 or 0.01).Immunohistological staining showed that the protein expressions of FN , collagenⅣand TIMP-2 significantly increased in glomeruli, while MMP-2 protein significantly decreased in diabetic rats (P<0.05 or 0.01).The abnormal level of these proteins was partly reversed in group C (P<0.05).Conclusion Artemisinin has some renoprotective effects in diabet-ic rats, partly through upregulation MMP -2 and downregulation TIMP -2 activity in glomeruli .